# Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children

> **NCT01646580** · PHASE4 · TERMINATED · sponsor: **Ferrer Internacional S.A.** · enrollment: 21 (actual)

## Conditions studied

- Dermatomycoses

## Interventions

- **DRUG:** ciclopirox

## Key facts

- **NCT ID:** NCT01646580
- **Lead sponsor:** Ferrer Internacional S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Low recruitment rate. with the final sample primary endpoint could be assessed.
- **Last updated:** 2012-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646580, "Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01646580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*